Showing results (1-10 of 308) with videos related to
Sort By:
Pageof 31
Oncoimmunology|November 20, 2012
Sound efficacy of prophylactic HPV vaccination: Basics and implicationsMatti Lehtinen, Jorma PaavonenWomen'S Health (London, England)|October 7, 2009
First-generation vaccines against human papillomavirusJorma Paavonen, Matti LehtinenAnnals of Medicine|April 3, 2008
Introducing human papillomavirus vaccines - questions remainJorma Paavonen, Matti LehtinenThe Journal of Infectious Diseases|August 16, 2021
Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian CancerJorma Paavonen, Renee Turzanski Fortner, Matti Lehtinen, et al.Expert Review of Vaccines|January 19, 2019
Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policiesMatti Lehtinen, Iacopo Baussano, Jorma Paavonen, et al.Journal of Medical Economics|May 21, 2010
Cost effectiveness of prophylactic HPV 16/18 vaccination in Finland: results from a modelling exerciseSaku Torvinen, Pekka Nieminen, Matti Lehtinen, et al.Pathogens (Basel, Switzerland)|December 7, 2019
The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in FinlandSuvi Korhonen, Kati Hokynar, Tiina Eriksson, et al.Vaccine|September 5, 2006
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countriesMatti Lehtinen, Rolando Herrero, Philippe Mayaud, et al.International Journal of Cancer|April 12, 2012
Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccinationJohanna Palmroth, Marko Merikukka, Jorma Paavonen, et al.Lakartidningen|November 25, 2003
[Preventive vaccines against papillomavirus and cervix cancer will soon enter clinical practice]Matti Lehtinen, Christian Malm, Dan Apter, et al.Pageof 31